Flexible, Science-Based Solutions to Meet the Needs of Your Patients

Customizable Solutions for Individualized Outcomes

The Similac® Liqui-Mix® System and Liquid Protein Fortifier can be used to customize calories and protein in an all-liquid solution.

Similac Product Infographic Similac Product Infographic

SIMILAC LIQUI-MIX SYSTEM 

  • All-liquid solution eliminates the need for most powder mixing 

  • Easy to customize feedings, including 20, 24, 26, 27, and 28 cal/fl oz

  • Easy to customize protein levels with Liquid Protein Fortifier

SIMILAC® NEOSURE® 

Nutrient-enriched* preterm post-discharge formula shown to improve overall growth1

CLINICALLY PROVEN SIMILAC® HUMAN MILK FORTIFIER HYDROLYZED PROTEIN CONCENTRATED LIQUID (HMF HP CL)

THE FIRST HUMAN MILK FORTIFIER WITH EXTENSIVELY HYDROLYZED PROTEIN

Supported by 5 clinical studies, our human milk fortifier has been shown to deliver excellent outcomes.2-6 

Similac Human Milk Fortifier Product Similac Human Milk Fortifier Product
Stomach Icon Stomach Icon

IMPROVED TOLERANCE3,4,6

DNA Icon DNA Icon

IMPROVED BLOOD UREA NITROGEN (BUN) LEVELS2,4

Scale Icon Scale Icon

IMPROVED WEIGHT GAIN2-4,6,‡

Tear Drop Icon Tear Drop Icon

FEWER ADVERSE EVENTS AND/OR LESS ACIDOSIS3-6

SAFE HANDLING AND USE

  • Packaged in single-use, ready-to-use packets for precise dosing and nutrient delivery 

  • Liquid form reduces the risk for environmental contamination 

  • Packets allow for aseptic handling when used as directed

  • Developed with a focus on safe handling for NICU use 

Similac Human Milk Fortifier Packet Similac Human Milk Fortifier Packet

KEY CLINICAL STUDY SHOWS IMPORTANT GAINS IN GROWTH7

Similac® offers the FIRST nonacidified human milk fortifier that has extensively hydrolyzed protein.

  • Similac HMF HP CL infants gained 0.5 lb more weight at study day 29, and both groups increased in weight and length over time 

  • Similac HMF HP CL delivers 4.3g§ of protein (g/kg/day)

Weight Gained Length Increased Weight Gained Length Increased

Evaluable patients (n = 75).

Hash marks indicate standard error. 

ǁ Weight, g. Repeated Measures Analysis main effect, P = 0.036; post-hoc per timepoint analysis: SDAY 29, P = 0.024. Length, cm. Repeated Measures Analysis main effect, P = 0.029; post-hoc per timepoint analysis: SDAY 22, P = 0.006, SDAY 29, P = 0.037.

¶ These infants strictly adhered to study protocol and received ≥95% of their total intake from human milk with their assigned study fortifier. 

FEATURES OF SIMILAC HMF HP CL

  • Extensively hydrolyzed protein source to help promote easy digestion

  • Has OptiGRO® for brain and eye development 

  • Low iron level provides flexibility to add iron as needed

Similac Human Milk Fortifier Product Similac Human Milk Fortifier Product

KEY CLINICAL STUDY SHOWS TOLERANCE7

Well tolerated 

  • Only 1 in 66 (1.5%) NICU patients in the Similac HMF HP CL group discontinued due to feeding intolerance 

  • No incidence of metabolic acidosis with infants fed Similac HMF HP CL or control  
     

Improved protein status 

  • Recent studies have identified BUN levels of >9 mg/dL as an indicator of protein sufficiency in preterm infants8-10 

  • BUN levels remained above 9 mg/dL in preterm infants receiving Similac HMF HP CL

     

Mean BUN levels

Mean Buns Chart Mean Buns Chart

EFFECTS OF AN ACIDIC pH ON HUMAN MILK

In vitro study of human milk acidified with citric acid to a pH of 4.511

Percent Change Chart Percent Change Chart

Similac HMF retains the pH of human milk to near neutral range, which should preserve the unique benefits of human milk.

* Increased protein, vitamins, and minerals compared to term infant formula.
† Launched in 2014. First nonacidified human milk fortifier that is hydrolyzed.
‡ In the Schanler study, weight gain was improved SDAY1-SDAY15.
§ Composition of human milk-based feedings at 120 kcal/kg and 24 Cal/fl oz. 

References: 1. Carver JD, et al. Pediatrics. 2001;107(4):683-689. 2. Kim J, et al. J Pediatr Gastroenterol Nutr. 2015;61(6):665-671. 3. Kumar N, et al. Am J Perinatol. 2017;34(14):1411-1416. 4. Schanler RJ, et al. J Pediatr. 2018;202:31-37.e2. 5. Lainwala S, et al. J Neonatal Perinatal Med. 2017;10(4):393-401. 6. Clark B, et al. J Acad Nutr Diet. 2017;117(9 suppl 1):A11. 7. Kim JH, et al. J Pediatr Gastroenterol Nutr. 2015;61(6):605-671. 8. Arslanoglu S, et al. J Perinatol. 2006;26:614-621. 9. Alan S, et al. Early Hum Dev. 2013;89:1017-1023. 10. Ergenekon E, et al. Turk J Pediatr. 2013;55:365-370. 11. Erickson T, et al. J Perinatol. 2013;33:371-373.